Ausgabe 4/2024
Inhalt (6 Artikel)
Review Article
Should Glucokinase be Given a Chance in Diabetes Therapeutics? A Clinical-Pharmacological Review of Dorzagliatin and Lessons Learned So Far
Upinder Kaur, Bhairav Kumar Pathak, Tharik Jalal Meerashahib, Dondapati Venkata Vamshi Krishna, Sankha Shubhra Chakrabarti
Open Access
Original Research Article
An Open-Label Study to Assess Monthly Risperidone Injections (180 mg) Following Switch from Daily Oral Risperidone (6 mg) in Stable Schizophrenic Patients
David P. Walling, Sunita N. Shinde, Janice M. Pogoda, Jahnavi Kharidia, Celine M. Laffont
Original Research Article
Effectiveness of Dose Increase in Upadacitinib from 15 mg to 30 mg for Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice in Japan
Teppei Hagino, Risa Hamada, Mai Yoshida, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Open Access
Original Research Article
Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE)
Xi Tan, Victoria Divino, James Amamoo, Lin Xie, Katharine B. Coyle, Cory L. Gamble, Mico Guevarra, Yurek Paprocki, Aaron A. King
Open Access
Research Letter
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
María Chaparro, Daniel Ceballos, Raquel Vicente, Javier P. Gisbert
Research Letter
Tolvaptan Treatment and Long-Term Impact on Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients: A Pilot Study
Gianni Carraro, Valentina Di Vico, Loris Martinetti, Elisabetta Bettin, Martina Cacciapuoti, Lucia Federica Stefanelli, Laura Gobbi, Federico Nalesso, Francesca Katiana Martino, Lorenzo A. Calò